Breast cancer screening in the Czech Republic: time trends in
performance indicators during the first seven years of the
organised programme

J 2011

Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme

MÁJEK, Ondřej; Jan DANEŠ; Miroslava SKOVAJSOVÁ; Helena BARTOŇKOVÁ; Lucie BUREŠOVÁ et al.

Základní údaje

Originální název

Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme

Autoři

MÁJEK, Ondřej ; Jan DANEŠ; Miroslava SKOVAJSOVÁ; Helena BARTOŇKOVÁ; Lucie BUREŠOVÁ; Daniel KLIMEŠ; Petr BRABEC; Pavel KOŽENÝ a Ladislav DUŠEK

Vydání

BMC Public Health, 2011, 1471-2458

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 1.997

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/11:00056971

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1186/1471-2458-11-288

UT WoS

000291549700003

Klíčová slova anglicky

The Czech Breast Cancer Screening Programme CBCSP

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 27. 6. 2012 17:13, RNDr. Ondřej Májek, Ph.D.

Anotace

V originále

Background: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. Methods: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. Results: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. Conclusions: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.

Návaznosti

NS10650, projekt VaV

Název: Výzkum metod standardizace zdravotní péče zaměřený na vývoj národní sady standardů zdravotních služeb

Investor: Ministerstvo zdravotnictví ČR, Výzkum metod standardizace zdravotní péče zaměřený na vývoj národní sady standardů zdravotních služeb

Citovat

MÁJEK, Ondřej; Jan DANEŠ; Miroslava SKOVAJSOVÁ; Helena BARTOŇKOVÁ; Lucie BUREŠOVÁ; Daniel KLIMEŠ; Petr BRABEC; Pavel KOŽENÝ a Ladislav DUŠEK. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health. 2011, roč. 11, May, s. "nestrankovano", 13 s. ISSN 1471-2458. Dostupné z: https://doi.org/10.1186/1471-2458-11-288.

@article{942593,
   author = {Májek, Ondřej and Daneš, Jan and Skovajsová, Miroslava and Bartoňková, Helena and Burešová, Lucie and Klimeš, Daniel and Brabec, Petr and Kožený, Pavel and Dušek, Ladislav},
   article_number = {May},
   doi = {https://doi.org/10.1186/1471-2458-11-288},
   keywords = {The Czech Breast Cancer Screening Programme CBCSP},
   language = {eng},
   issn = {1471-2458},
   journal = {BMC Public Health},
   title = {Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme},
   url = {http://www.biomedcentral.com/1471-2458/11/288},
   volume = {11},
   year = {2011}
}

TY  - JOUR
ID  - 942593
AU  - Májek, Ondřej - Daneš, Jan - Skovajsová, Miroslava - Bartoňková, Helena - Burešová, Lucie - Klimeš, Daniel - Brabec, Petr - Kožený, Pavel - Dušek, Ladislav
PY  - 2011
TI  - Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
JF  - BMC Public Health
VL  - 11
IS  - May
SP  - "nestrankovano"
EP  - "nestrankovano"
SN  - 14712458
KW  - The Czech Breast Cancer Screening Programme CBCSP
UR  - http://www.biomedcentral.com/1471-2458/11/288
L2  - http://www.biomedcentral.com/1471-2458/11/288
N2  - Background: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. Methods: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. Results: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. Conclusions: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.
ER  -

MÁJEK, Ondřej; Jan DANEŠ; Miroslava SKOVAJSOVÁ; Helena BARTOŇKOVÁ; Lucie BUREŠOVÁ; Daniel KLIMEŠ; Petr BRABEC; Pavel KOŽENÝ a Ladislav DUŠEK. Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. \textit{BMC Public Health}. 2011, roč.~11, May, s.~''nestrankovano'', 13 s. ISSN~1471-2458. Dostupné z: https://doi.org/10.1186/1471-2458-11-288.

Přehled o publikaci